Hercules Capital Cash on Hand 2010-2024 | HTGC
Hercules Capital cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Hercules Capital Annual Cash on Hand (Millions of US $) |
2023 |
$116 |
2022 |
$26 |
2021 |
$136 |
2020 |
$238 |
2019 |
$115 |
2018 |
$46 |
2017 |
$95 |
2016 |
$21 |
2015 |
$104 |
2014 |
$240 |
2013 |
$275 |
2012 |
$183 |
2011 |
$64 |
2010 |
$107 |
2009 |
$125 |
Hercules Capital Quarterly Cash on Hand (Millions of US $) |
2024-09-30 |
$44 |
2024-06-30 |
$39 |
2024-03-31 |
$60 |
2023-12-31 |
$116 |
2023-09-30 |
$37 |
2023-06-30 |
$74 |
2023-03-31 |
$79 |
2022-12-31 |
$26 |
2022-09-30 |
$65 |
2022-06-30 |
$119 |
2022-03-31 |
$62 |
2021-12-31 |
$136 |
2021-09-30 |
$249 |
2021-06-30 |
$24 |
2021-03-31 |
$87 |
2020-12-31 |
$238 |
2020-09-30 |
$48 |
2020-06-30 |
$69 |
2020-03-31 |
$56 |
2019-12-31 |
$115 |
2019-09-30 |
$36 |
2019-06-30 |
$29 |
2019-03-31 |
$27 |
2018-12-31 |
$46 |
2018-09-30 |
$46 |
2018-06-30 |
$75 |
2018-03-31 |
$122 |
2017-12-31 |
$95 |
2017-09-30 |
$148 |
2017-06-30 |
$178 |
2017-03-31 |
$161 |
2016-12-31 |
$21 |
2016-09-30 |
$78 |
2016-06-30 |
$63 |
2016-03-31 |
$17 |
2015-12-31 |
$104 |
2015-09-30 |
$153 |
2015-06-30 |
$128 |
2015-03-31 |
$194 |
2014-12-31 |
$240 |
2014-09-30 |
$161 |
2014-06-30 |
$119 |
2014-03-31 |
$229 |
2013-12-31 |
$275 |
2013-09-30 |
$209 |
2013-06-30 |
$136 |
2013-03-31 |
$208 |
2012-12-31 |
$183 |
2012-09-30 |
$107 |
2012-06-30 |
$56 |
2012-03-31 |
$48 |
2011-12-31 |
$64 |
2011-09-30 |
$96 |
2011-06-30 |
$198 |
2011-03-31 |
$114 |
2010-12-31 |
$107 |
2010-09-30 |
$83 |
2010-06-30 |
$53 |
2010-03-31 |
$106 |
2009-12-31 |
$125 |
2009-09-30 |
$77 |
2009-06-30 |
$37 |
2009-03-31 |
$8 |
Sector |
Industry |
Market Cap |
Revenue |
Finance |
Finance - SBIC & Commercial |
$3.244B |
$0.461B |
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|